method for treating or preventing l-dopa, dopamine agonist and / or dopamine enhancer-induced disorders in an individual in need thereof, agent, composition, use of one or more agents and method for treating parkinson's disease
WO2010084356A1
Treatment of neurotrophic factor mediated disorders
CN102355902A
Treatment of neurotrophic factor mediated disorders
US2009264376A1
Hoodia plant extract with improved flavor
GB0613518D0
Chemical compounds
GB0424528D0
Chemical compounds
GB0411703D0
Selective separation or extraction of steroidal glycosides
GB0409567D0
Chemical compounds
TW200505461A
Moldulation of ATP production or content in the hypothalamus
CA2503899A1
Stereospecific reduction of sapogen-3-ones
CN102727501A
Uses of sapogenins and their derivatives
NZ563183A
Therapeutic methods and uses of sapogenins and their derivatives
CN1642558A
Uses of sapogenins and their derivatives
TW200833344A
Therapeutic methods and uses of sapogenins and the
NZ535093A
Therapeutic methods and uses of sapogenins and their derivatives
GB0301505D0
Stereospecific synthesis of sapogenins
GB0225106D0
Synthesis of 3 hydroxy-5 -steroids
NZ540712A
Steroidal sapogenin derivatives, their synthesis and their use in the treatment of cognitive dysfunction
MY134920A
5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
AU2774002A
Steroidal sapogenins and their derivatives for treating Alzheimer's disease
